Cellebrite DI [CLBT] vs Oracle [ORCL] Detailed Stock Comparison

Cellebrite DI Ltd.

NASDAQ
Loading...

Oracle Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Cellebrite DI Ltd. wins in 7 metrics, Oracle Corporation wins in 13 metrics, with 0 ties. Oracle Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Cellebrite DI Ltd. Oracle Corporation Better
P/E Ratio (TTM) 42.90 31.65 Oracle Corporation
Price-to-Book Ratio 6.83 15.11 Cellebrite DI Ltd.
Debt-to-Equity Ratio 4.68 415.27 Cellebrite DI Ltd.
PEG Ratio 3.43 1.38 Oracle Corporation
EV/EBITDA 37.06 23.16 Oracle Corporation
Profit Margin (TTM) 16.47% 25.30% Oracle Corporation
Operating Margin (TTM) 16.15% 32.68% Oracle Corporation
EBITDA Margin (TTM) 16.15% 32.68% Oracle Corporation
Return on Equity 19.10% 57.57% Oracle Corporation
Return on Assets (TTM) 5.10% 6.34% Oracle Corporation
Free Cash Flow (TTM) $160.32M $-394.00M Cellebrite DI Ltd.
Dividend Yield N/A 1.01% N/A
1-Year Return -11.69% 36.40% Oracle Corporation
Price-to-Sales Ratio (TTM) 6.97 7.91 Cellebrite DI Ltd.
Enterprise Value $2.90B $635.53B Oracle Corporation
EV/Revenue Ratio 6.10 9.92 Cellebrite DI Ltd.
Gross Profit Margin (TTM) 84.71% 64.56% Cellebrite DI Ltd.
Revenue per Share (TTM) $2 $23 Oracle Corporation
Earnings per Share (Diluted) $0.31 $5.57 Oracle Corporation
Beta (Stock Volatility) 1.28 1.60 Cellebrite DI Ltd.
Short % of Float 3.52% 1.62% Oracle Corporation

Cellebrite DI Ltd. vs Oracle Corporation Stock Performance Analysis

Loading Price Chart...

CLBT
ORCL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Cellebrite DI Ltd.-5.34%11.65%3.96%3.20%-21.22%-20.52%
Oracle Corporation-5.83%20.62%27.76%54.57%10.88%17.69%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Cellebrite DI Ltd.-11.69%157.97%48.79%52.48%52.48%52.48%
Oracle Corporation36.40%113.22%172.39%477.44%598.36%1,495.62%

Performance & Financial Health Analysis: Cellebrite DI Ltd. vs Oracle Corporation

MetricCLBTORCL
Market Information
Market Cap i$3.18B$498.36B
Market Cap CategoryMid capMega cap
10 Day Avg. Volume i2,014,39140,165,144
90 Day Avg. Volume i1,712,49428,439,468
Last Close$14.18$230.33
52 Week Range$11.02 - $19.98$134.57 - $345.72
% from 52W High-29.03%-33.38%
All-Time High$26.30 (Feb 03, 2025)$345.72 (Sep 10, 2025)
% from All-Time High-46.08%-33.38%
Growth Metrics
Quarterly Revenue Growth0.18%0.22%
Quarterly Earnings Growth0.10%0.27%
Financial Health
Profit Margin (TTM) i0.16%0.25%
Operating Margin (TTM) i0.16%0.33%
Return on Equity (TTM) i0.19%0.58%
Debt to Equity (MRQ) i4.68415.27
Cash & Liquidity
Book Value per Share (MRQ)$1.95$11.67
Cash per Share (MRQ)$1.75$13.61
Operating Cash Flow (TTM) i$173.54M$23.51B
Levered Free Cash Flow (TTM) i$140.94M$-22,298,499,072
Dividends
Last 12-Month Dividend Yield iN/A1.01%
Last 12-Month Dividend iN/A$2.00

Valuation & Enterprise Metrics Analysis: Cellebrite DI Ltd. vs Oracle Corporation

MetricCLBT (Apr 24, 2026)ORCL (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i42.9031.65
Forward P/E i21.8022.08
PEG Ratio i3.431.38
Price to Sales (TTM) i6.977.91
Price to Book (MRQ) i6.8315.11
Market Capitalization
Market Capitalization i$3.18B$498.36B
Enterprise Value i$2.90B$635.53B
Enterprise Value Metrics
Enterprise to Revenue i6.109.92
Enterprise to EBITDA i37.0623.16
Risk & Other Metrics
Beta i1.281.60
Book Value per Share (MRQ) i$1.95$11.67

Financial Statements Comparison: Cellebrite DI Ltd. vs Oracle Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCLBT (2025)ORCL (2025)
Revenue/Sales i475.68M57.40B
Cost of Goods Sold i75.17M16.93B
COGS % of Revenue i15.8%29.5%
Gross Profit i400.50M40.47B
Gross Margin i84.2%70.5%
Research & Development i113.88M9.86B
Operating Income (EBIT) i66.48M18.05B
Operating Margin i14.0%31.5%
EBITDA i102.33M24.71B
EBITDA Margin i21.5%43.1%
Pre-Tax Income i90.68M14.16B
Pre-Tax Income % of Revenue i19.1%24.7%
Income Tax i12.35M1.72B
Income Tax % of Revenue i2.6%3.0%
Net Income (Profit) i78.33M12.44B
Profit Margin i16.5%21.7%

Balance Sheet & Liquidity Metrics

MetricCLBT (2025)ORCL (2025)
Cash & Equivalents i124.46M10.79B
Total Current Assets i575.85M24.58B
Total Current Assets % of Revenue i121.1%42.8%
Total Current Liabilities i369.66M32.64B
Total Current Liabilities % of Revenue i77.7%56.9%
Long-Term Debt i18.67M96.83B
Long-Term Debt % of Revenue i3.9%168.7%
Total Shareholders Equity i484.32M20.97B
Retained Earnings i-86.54M-15.48B
Retained Earnings % of Revenue i-18.2%-27.0%
Property, Plant & Equipment i16.95M0

Cash Flow Statement Comparison

MetricCLBT (2025)ORCL (2025)
Operating Cash Flow i163.74M21.21B
Operating Cash Flow % of Revenue i34.4%37.0%
Capital Expenditures i-13.23MN/A
Free Cash Flow i160.32M-394.00M
FCF Margin i33.7%-0.7%
Debt Repayment iN/A-15.84B
Common Stock Repurchase iN/A-1.50B

Short Interest & Institutional Ownership Analysis

MetricCLBTORCL
Shares Short i4.91M27.67M
Short Ratio i2.881.00
Short % of Float i3.52%1.62%
Shares Outstanding i248.58M2.88B
Float Shares i122.90M1.71B
% Held by Insiders i43.14%40.55%
% Held by Institutions i53.29%44.43%
% Held by Public i3.57%15.02%

Dividend Analysis & Yield Comparison: Cellebrite DI Ltd. vs Oracle Corporation

MetricCLBTORCL
Last 12-Month Dividend iN/A$2.00
Last 12-Month Dividend Yield iN/A1.01%
3-Year Avg Annual Dividend iN/A$1.73
3-Year Avg Dividend Yield iN/A0.30%
3-Year Total Dividends iN/A$5.20
Ex-Dividend DateN/AJan 09, 2026